MedTrace Logo

PROMBot-HSM-FA: Protocol for a Feasibility Study of a Chatbot Platform to Collect Patient-reported Outcomes After AF Ablation

NCT07237178 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2025-11-26

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if using a WhatsApp-based chatbot called PROMBot-FA can help people recover after atrial fibrillation ablation. The main questions it aims to answer are:

* Is the chatbot easy and practical for people to use after their procedure?
* Do people find the chatbot helpful for sharing their symptoms and health updates?

Researchers will compare follow-up care supported by the chatbot to standard hospital follow-up visits. Participants will:

* Be randomly assigned to either use the chatbot or receive usual follow-up care.
* Report their symptoms, well-being, and any problems after ablation for 3 months.
* Complete short questionnaires about their experience using the chatbot.

This study will help researchers understand whether chatbot follow-up is feasible and acceptable for people after atrial fibrillation ablation and guide future larger studies.

Conditions

  • Atrial Fibrillation (AF)
  • Catheter Ablation

Interventions

BEHAVIORAL

PROMBot-FA Chatbot-Supported Follow-Up

Use of the PROMBot-FA WhatsApp-based chatbot to collect patient-reported outcomes and clinical parameters during 3 months after ablation.

OTHER

Standard Care (in control arm)

Routine follow-up according to institutional protocols without chatbot support.

Sponsors & Collaborators

  • Ana Rita Londral, PhD

    lead OTHER

Principal Investigators

  • Sérgio Laranjo, MD, PhD, PGDipHM, FESC, FACC · Hospital de Santa Marta, ULS de São José

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-04-30
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07237178 on ClinicalTrials.gov